α2β adrenoreceptor 301–303 deletion polymorphism in polycystic ovary syndrome
Autor: | Venetsana Kyriazopoulou, Sosanna Kritikou, Alexandros D. Saltamavros, George Adonakis, Christodoulos S. Flordellis, Kostas Spyropoulos, Neoklis A. Georgopoulos, Kleanthis D. Koufogiannis, Vasiliki Koika, G Kourounis |
---|---|
Rok vydání: | 2007 |
Předmět: |
Adult
medicine.medical_specialty Genotype Insulin resistance Receptors Adrenergic alpha-2 Internal medicine Diabetes mellitus medicine Humans Receptor Polymorphism Genetic Endocrine and Autonomic Systems business.industry medicine.disease Polycystic ovary Obesity Endocrinology Basal metabolic rate Female Neurology (clinical) medicine.symptom business Weight gain Gene Deletion Polycystic Ovary Syndrome |
Zdroj: | Clinical Autonomic Research. 17:112-114 |
ISSN: | 1619-1560 0959-9851 |
DOI: | 10.1007/s10286-007-0403-6 |
Popis: | alpha(2beta) adrenoreceptor 301-303 deletion polymorphism does not influence basal metabolic rate, insulin resistance or weight gain in Greek women with polycystic ovary syndrome. |
Databáze: | OpenAIRE |
Externí odkaz: |